km.idaeo.ai · IDAEO 知識庫

🏛 本文屬於主題館「reports」 →

補骨粉會有後遺症嗎？失敗了會怎樣？｜證據鏈

km 編輯部2026-08-13閱讀約 26 分鐘
#證據鏈#牙醫KM#台灣#補骨

本頁是〈補骨粉會有後遺症嗎？失敗了會怎樣？〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

補骨粉會有後遺症嗎？失敗了會怎樣？｜證據鏈

F-Units（事實單元帳）

  • F1｜confidence: verified｜basis: peer_reviewed（PMID 28938030）｜period: 檢索至 2015-07，2018 刊出｜geo: universal｜span: 「The weighted complication rate of the overall soft tissue complications … was 16.8% (95% CI = 10.6% to 25.4%)」「soft tissue lesions were reported as early as 1 week and as late as 6 months」｜caveat: 為 GBR 軟組織併發症加權率，非個人風險
  • F2｜confidence: verified｜basis: peer_reviewed（PMID 35048503）｜period: 檢索至 2020-11，2022 刊出｜geo: universal｜span: 「incidence proportion of healing complications … 11.0%」「membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation … 8.7% … 0.7% … 0.5%」「RoM of vertical bone gained was 0.65 … and 0.62」「The RoM of vertical bone gained was 0.65 [95% CI = 0.47, 0.91] and 0.62 [95% CI = 0.45, 0.85] when membrane exposure without suppuration and abscess formation without membrane exposure occurred respectively, in comparison to uneventful healing.」「The site-level incidence proportion of membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation without membrane exposure was 8.7% [95% CI = 4.2, 14.2], 0.7% [95% CI = 0.0, 2.9], and 0.5% [95% CI = 0.0, 1.7], respectively.」｜caveat: 限垂直 GBR，位點層級
  • F3｜confidence: verified｜basis: peer_reviewed（PMID 30667522）｜period: 2019 刊出｜geo: universal｜span: 「complications rate of 47.3% for distraction osteogenesis, 4.18 mm and 12.1% for guided bone regeneration (GBR), and 3.46 mm and 23.9% for bone blocks」「although complications are common」｜caveat: 垂直骨增量情境
  • F4｜confidence: verified｜basis: peer_reviewed（PMID 35737681）｜period: 檢索 1960-01 至 2021-06｜geo: universal｜span: 「Postoperative pain, swelling, and edema were widely reported」「sinus membrane perforation (SMP), wound dehiscence, graft exposure and failure, and sinusitis」「benign paroxysmal positional vertigo following TSFE was significant in certain selected studies」｜caveat: 74 篇、4,411 例上顎竇增高術
  • F5｜confidence: verified｜basis: peer_reviewed（PMID 34250560）｜period: 2008 至 2020-04 文獻｜geo: universal｜span: 「survival rate of 97.68% … 98.88%」「The rate of Schneiderian membrane perforation … was 30.6%」「is not a risk factor for dental implant survival (p=0.229; …)」「A total of 1115 implants were placed under previously perforated and repaired membranes, obtaining a survival rate of 97.68%, while 2495 implants were placed below sinus membranes that were not damaged during surgery, obtaining a survival rate of 98.88%.」｜caveat: 限側窗術式、修補後
  • F6｜confidence: verified｜basis: peer_reviewed（PMID 37752820）｜period: 2023 刊出｜geo: universal｜span: 「regeneration occurred in a predictable way」「several complications (including exposure, infection, and soft tissue dehiscence) were reported, which tend to be higher when using cross-linked collagen membranes」｜caveat: 網絡統合分析，限同期植體置入之 GBR
  • F7｜confidence: verified｜basis: peer_reviewed（PMID 29231263）｜period: 2018 刊出｜geo: universal｜span: 「moderate limitation in the 1st 48 hr post-surgery but little or none by day 3 or 4」「Mild to moderate pain and interference to daily activities were reported for the first 3 days requiring the use of NSAIDs only」「mild to moderate pain and restrictions to daily activities for 48-72 hr」「morbidity were greater with autogenous bone harvesting」｜caveat: 60 人前瞻性對照試驗，上顎竇側窗術式；個別差異大
  • F8｜confidence: verified｜basis: peer_reviewed（PMID 35056347）｜period: 2021 刊出，292 篇納入｜geo: universal｜span: 「implants in smokers had a higher failure risk in comparison with non-smokers (OR 2.402, p < 0.001)」「MBL mean difference (MD) between the groups was 0.580 mm」｜caveat: 觀察性證據合併，非因果推論
  • F9｜confidence: verified｜basis: peer_reviewed（PMID 28332067）｜period: 2017 刊出｜geo: universal｜span: 「Postoperative infection and implant loss occurred in 8/121 sinuses (6.6%)」「Infection had the strongest correlation to preoperative chronic sinusitis (p = 0.007)」｜caveat: 單中心回溯，109 人
  • F10｜confidence: verified｜basis: peer_reviewed（PMID 36807599）｜period: 檢索至 2022-08｜geo: universal｜span: 「diabetic patients with dental implants and good glycaemic control have a significantly lower risk of peri-implantitis (odds ratio [OR] = 0.16」「risk of dental implant failure (or = 3.76; 95% ci: 1.50-9.45; …) appears to be greater under irregular or no SPC」｜caveat: 間接證據，作者標註證據侷限
  • F11｜confidence: verified｜basis: clinical_guideline（PMID 35300956，AAOMS 2022 立場書）｜period: 2022 更新版｜geo: universal｜span: 「Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ)」｜caveat: 本卡僅引用其存在與適用族群，不引用個別處置建議
  • F12｜confidence: verified｜basis: peer_reviewed（PMID 35472121）｜period: 2022 刊出｜geo: universal｜span: 「a protocol specific to the classification and management of d-PTFE membrane healing complications is required and is thus presented in this paper」｜caveat: 限 d-PTFE 膜材，說明「暴露需專業分類處置」而非自行處理
  • F13｜confidence: verified｜basis: peer_reviewed（PMID 37109671）｜period: 2023 刊出，12 篇 RCT｜geo: universal｜span: 「The routine use of prophylactic antibiotics to prevent infection in dental implant placement was found to be not sufficiently effective to justify routine use」「Clear clinical assessment pathways … are required」｜caveat: 屬臨床決策層面，病人不得據此自行停藥
  • F14｜confidence: verified｜basis: peer_reviewed（PMID 30155575）｜period: 2019 刊出｜geo: universal｜span: 「The interruption of antithrombotics prior to tooth removal because of the fear of bleeding or following postoperative bleeding increases the risk of thromboembolic events」「The investigated haemostatics included gauze pressure」｜caveat: 原研究情境為拔牙，本卡僅引用止血措施類別與停藥風險
  • F15｜confidence: verified｜basis: peer_reviewed（PMID 34074573）｜period: 1997 至 2013 全國登錄，2022 刊出｜geo: universal｜span: 「other implant-related complications (infection, implant malposition, lack of bone at implant site, mechanical damage, or failed osseointegration)」｜caveat: 芬蘭理賠登錄資料，僅用於「神經損傷屬已知併發症類別」
  • F16｜confidence: verified（2026-08-05 複驗，同 #9 卡錨 C2）｜basis: law｜period: 現行條文｜geo: TW｜span: 《全民健康保險法》第 51 條「十一、義齒、義眼、眼鏡、助聽器、輪椅、拐杖及其他非具積極治療性之裝具。」｜caveat: 個別給付以健保署現行公告為準，本卡不作給付判定
  • F17｜confidence: verified（2026-08-05）｜basis: law｜period: 現行條文｜geo: TW｜span: 《醫療法》第 63 條「醫療機構實施手術，應向病人或其法定代理人、配偶、親屬或關係人說明手術原因、手術成功率或可能發生之併發症及危險，並經其同意，簽具手術同意書及麻醉同意書，始得為之。」｜caveat: 條文引述，非法律意見
  • F18｜confidence: verified（2026-08-05）｜basis: law｜period: 現行條文｜geo: TW｜span: 《醫療法》第 81 條「醫療機構診治病人時，應向病人或其法定代理人、配偶、親屬或關係人告知其病情、治療方針、處置、用藥、預後情形及可能之不良反應。」｜caveat: 條文引述，非法律意見
  • F19｜confidence: verified（2026-08-05）｜basis: official_statement｜period: 資料集現況｜geo: TW｜span: 政府資料開放平臺資料集「臺北市醫療收費標準」，提供機關臺北市政府衛生局｜caveat: 單一縣市例證；其他縣市頁面放量前逐一補驗；同 #9 卡錨 C3 家族
  • F20｜confidence: verified（入口可及，2026-08-05 複驗 200）｜basis: official_statement｜period: 入口現況｜geo: TW｜span: 健保署醫材比價網入口 info.nhi.gov.tw/INAE2000/INAE2010S01｜caveat: 頁面內容為 JS 動態載入，curl 無法逐字比對，名稱與收錄範圍依 #9 卡錨 C4 查證；骨移植材料是否在可查品項，發布前補實測；2026-08-05 OP 實測更正：該網兩軌類別皆不含牙科，骨移植材料無法由此查證
  • F21｜confidence: verified｜basis: internal_data｜period: 2025-03 至 2026-08 GSC｜geo: TW｜span: backlog #28「補骨粉後遺症」等 7 詞項合計曝光 121,073，跨 4 站｜caveat: 曝光為屬性級數字，非去重流量
  • F22｜confidence: 結構性整理（編輯框架，非外部事實宣稱）｜basis: editorial_framework｜period: 2026-08-05｜geo: universal｜span: 「文獻中廣泛報告的反應／該安排回診／該盡快就醫」三級分辨框架與「一天比一天輕」的走勢判斷，為本站依 F1 至 F15 文獻整理的溝通用架構｜caveat: 非診斷工具，不取代臨床判斷

來源清單

取用日期均為 2026-08-05；PubMed 條目以 E-utilities efetch 取得摘要原文，並逐條實測條目頁回應 200。

  1. Lim G, et al. Wound Healing Complications Following Guided Bone Regeneration for Ridge Augmentation: A Systematic Review and Meta-Analysis. Int J Oral Maxillofac Implants. 2018;33(1):41-50. PMID 28938030
  2. Tay JRH, et al. Healing complications and their detrimental effects on bone gain in vertical-guided bone regeneration: A systematic review and meta-analysis. Clin Implant Dent Relat Res. 2022;24(1):43-71. PMID 35048503
  3. Urban IA, et al. Effectiveness of vertical ridge augmentation interventions: A systematic review and meta-analysis. J Clin Periodontol. 2019;46 Suppl 21:319-339. PMID 30667522
  4. Hsu YT, et al. Complications of sinus floor elevation procedure and management strategies: A systematic review. Clin Implant Dent Relat Res. 2022;24(6):740-765. PMID 35737681
  5. Díaz-Olivares LA, et al. Management of Schneiderian membrane perforations during maxillary sinus floor augmentation with lateral approach in relation to subsequent implant survival rates: a systematic review and meta-analysis. Int J Implant Dent. 2021;7(1):91. PMID 34250560
  6. Calciolari E, et al. Efficacy of biomaterials for lateral bone augmentation performed with guided bone regeneration. A network meta-analysis. Periodontol 2000. 2023;93(1):77-106. PMID 37752820
  7. Alayan J, Ivanovski S. A prospective controlled trial comparing xenograft/autogenous bone and collagen-stabilized xenograft for maxillary sinus augmentation. Clin Oral Implants Res. 2018;29(2):248-262. PMID 29231263
  8. Mustapha AD, et al. Smoking and Dental Implants: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1):39. PMID 35056347
  9. Kozuma A, et al. Preoperative chronic sinusitis as significant cause of postoperative infection and implant loss after sinus augmentation from a lateral approach. Oral Maxillofac Surg. 2017;21(2):193-200. PMID 28332067
  10. Carra MC, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023;50 Suppl 26:77-112. PMID 36807599
  11. Ruggiero SL, et al. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-943. PMID 35300956
  12. Vroom MG, et al. Clinical Classification of Healing Complications and Management in Guided Bone Regeneration Procedures with a Nonresorbable d-PTFE Membrane. Int J Periodontics Restorative Dent. 2022;42(3):419-427. PMID 35472121
  13. Torof E, et al. Antibiotic Use in Dental Implant Procedures: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2023;59(4):713. PMID 37109671
  14. Ockerman A, et al. Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review. Clin Oral Investig. 2019;23(4):1695-1708. PMID 30155575
  15. Pääsky E, et al. Are women more susceptible than men to iatrogenic inferior alveolar nerve injury in dental implant surgery? Int J Oral Maxillofac Surg. 2022;51(2):251-256. PMID 34074573
  16. 全民健康保險法 第 51 條（全國法規資料庫）
  17. 醫療法 第 63 條（全國法規資料庫）
  18. 醫療法 第 81 條（全國法規資料庫）
  19. 政府資料開放平臺：臺北市醫療收費標準（提供機關：臺北市政府衛生局）
  20. 衛生福利部中央健康保險署 醫材比價網（入口）
  21. 內部數據：`analysis/reports/km-dental-backlog.md` #28 附錄（詞×站×曝光逐筆可對帳）
  22. 編輯框架：本站三級分辨結構（無外部來源，標示為結構性整理）

內部引用鏈

  • 費用怎麼問、報價單怎麼讀：植牙一顆到底多少錢？（KM-DENTAL-09）
  • 「牙套」名稱分流與費用組成：「牙套」要多少錢？（KM-DENTAL-08）
發布閘門提醒：本卡為 draft。四語（zh-Hans／en／ja）未產前不得進 km_entries；F20 的骨移植材料品項收錄範圍未實測前，該句維持「查證管道」定位、不得改寫成價格陳述。

FAQ

什麼情況要盡快就醫，不能等？
化膿或形成膿瘍、明顯感染徵象、腫脹或疼痛不減反增、出血持續且加壓後仍難以控制，或嘴唇、下巴或舌頭持續麻木時，請盡快就醫 [F2][F6][F7][F22][F14][F15]。
どんな時は速やかに受診すべきですか？ — 排膿または膿瘍の形成、明らかな感染徴候、腫れや痛みが軽くならずむしろ悪化すること、出血が続くか圧迫しても止まりにくいこと、または唇・あご・舌のしびれが続くときは、速やかに受診してください [F2][F6][F7][F22][F14][F15]。
When do I need prompt medical care rather than wait? — Pus or an abscess, clear signs of infection, swelling or pain that is not easing and instead is getting worse, bleeding that continues or remains difficult to control after pressure, or persistent numbness of the lip, chin, or tongue all warrant prompt medical care [F2][F6][F7][F22][F14][F15].
骨粉「跑出來」是不是代表失敗了？
**不必然。** 顆粒外露多與傷口裂開或覆蓋膜暴露相關，系統性回顧把移植材料外露列為需要介入處理的併發症之一 [F4]，而膜暴露有專門的分類與處置流程，由醫師依材質與程度判斷 [F12]。文獻顯示併發症會讓骨增量減少（均值比 0.65 與 0.62）[F2]，但這與「整個療程作廢」是兩件事；請回診讓醫師評估，不要自行拔除外露物。
骨補填材が「出てきた」ことは失敗を意味しますか？ — **必ずしもそうではありません。** 粒子の露出は、創部離開またはバリア膜露出に関連することが多いです。系統的レビューでは、移植材料の露出を介入処置が必要になり得る合併症の一つに挙げ [F4]、膜露出には材料と程度に応じて医師が判断する専用の分類・処置の流れがあります [F12]。文献は、合併症により骨増量が減少すること（平均比 0.65 と 0.62）を示しています [F2]。ただし、これは治療全体が無効になることとは別です。受診して評価を受け、露出物を自分で取り除かないでください。
Does graft material “coming out” mean it has failed? — **Not necessarily.** Exposed particles are often related to wound dehiscence or barrier-membrane exposure. A systematic review lists graft exposure as a complication that may need intervention [F4], and membrane exposure has specific classification and management pathways that a clinician judges according to the material and extent [F12]. The literature shows that complications reduce bone gain (mean ratios 0.65 and 0.62) [F2], but that is different from saying the whole course of treatment has been voided. Return for an assessment; do not remove exposed material yourself.
腫脹要多久才會消？
**依文獻描述的一般時程，頭 48 小時較明顯，術後第 3 至 4 天多降為輕微或沒有影響。** 前瞻性對照試驗記錄的是術後 48 至 72 小時的輕到中度疼痛與活動限制 [F7]。實際恢復速度因人而異，須由牙醫師評估。
腫れはどのくらいで引きますか？ — **文献が述べる一般的な経過では、最初の 48 時間がより目立ち、術後 3〜4 日には多くの人で軽微または影響なしになります。** 前向き対照試験が記録したのは、術後 48〜72 時間の軽度から中等度の痛みと日常活動制限です [F7]。実際の回復速度は人により異なり、歯科医師の評価が必要です。
How long will the swelling take to go away? — **In the general timeline described in the literature, it is more noticeable during the first 48 hours, and by postoperative day 3 or 4 it is little or no impact for most people.** The prospective controlled trial recorded mild-to-moderate pain and limitation of daily activities for 48 to 72 hours after surgery [F7]. Actual recovery speed varies by person and requires a dentist’s assessment.

來源錨定

引用本文

km 編輯部・《補骨粉會有後遺症嗎？失敗了會怎樣？｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/reports/dental-bone-graft-complications-evidence

相關文章

更新 2026-08-13T14:17:05.115Z · server-rendered · four-language · IDAEO 知識庫